A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM
NOT ENROLLING
Trial ID:
NCT02658981 Protocol # :
16-016
Phase
I
Disease Sites
Brain and Nervous System
Principal Investigator
Wen, Patrick, Yung
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #16-016
16-016